Literature DB >> 8627766

Cyclin-dependent kinases phosphorylate the adenovirus E1A protein, enhancing its ability to bind pRb and disrupt pRb-E2F complexes.

A Mal1, A Piotrkowski, M L Harter.   

Abstract

The adenovirus E1A protein of 243 amino acids has been shown to affect a variety of cellular functions, most notably the immortalization of primary cells and the promotion of quiescent cells into S phase. The activity of E1A is derived, in part, from its association with various cellular proteins, many of which play important roles in regulating cell cycle progression. E1A is known to have multiple sites of phosphorylation. It has been suggested that cell cycle-dependent phosphorylation may also control some of E1A's functions. We find now that immune complexes of cyclin-dependent kinases such as cdk4, cdk2, and cdc2 are all capable of phosphorylating E1A in vitro. Additionally, the sites on E1A phosphorylated by these kinases in vitro are similar to the E1A sites phosphorylated in vivo. We have also found that a phosphorylated E1A is far more efficient than an unphosphorylated E1A in associating with pRB and in disrupting E2F/DP-pRB complexes as well. On the basis of our findings and the differences in timing and expression levels of the various cyclins regulating cdks, we suggest that E1A functions at different control points in the cell cycle and that phosphorylation controls, to some extent, its biological functions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8627766      PMCID: PMC190149     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  117 in total

1.  Detection of cellular proteins associated with human adenovirus type 5 early region 1A polypeptides.

Authors:  S P Yee; P E Branton
Journal:  Virology       Date:  1985-11       Impact factor: 3.616

2.  G1 cyclins control the retinoblastoma gene product growth regulation activity via upstream mechanisms.

Authors:  L E Horton; Y Qian; D J Templeton
Journal:  Cell Growth Differ       Date:  1995-04

Review 3.  The retinoblastoma protein and cell cycle control.

Authors:  R A Weinberg
Journal:  Cell       Date:  1995-05-05       Impact factor: 41.582

4.  In vivo association of E2F and DP family proteins.

Authors:  C L Wu; L R Zukerberg; C Ngwu; E Harlow; J A Lees
Journal:  Mol Cell Biol       Date:  1995-05       Impact factor: 4.272

Review 5.  Viral oncoprotein binding to pRB, p107, p130, and p300.

Authors:  J W Ludlow; G R Skuse
Journal:  Virus Res       Date:  1995-02       Impact factor: 3.303

Review 6.  Transcriptional regulation during the mammalian cell cycle.

Authors:  R Müller
Journal:  Trends Genet       Date:  1995-05       Impact factor: 11.639

7.  Partition of E1A proteins between soluble and structural fractions of adenovirus-infected and -transformed cells.

Authors:  P K Chatterjee; S J Flint
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

8.  Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300.

Authors:  J S Lee; K M Galvin; R H See; R Eckner; D Livingston; E Moran; Y Shi
Journal:  Genes Dev       Date:  1995-05-15       Impact factor: 11.361

9.  Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes.

Authors:  R L Beijersbergen; L Carlée; R M Kerkhoven; R Bernards
Journal:  Genes Dev       Date:  1995-06-01       Impact factor: 11.361

10.  The release of growth arrest by microinjection of adenovirus E1A DNA.

Authors:  S Stabel; P Argos; L Philipson
Journal:  EMBO J       Date:  1985-09       Impact factor: 11.598

View more
  7 in total

1.  Inactivation of p21 by E1A leads to the induction of apoptosis in DNA-damaged cells.

Authors:  D Chattopadhyay; M K Ghosh; A Mal; M L Harter
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

2.  Comparative sequence analysis of the largest E1A proteins of human and simian adenoviruses.

Authors:  Nikita Avvakumov; Russ Wheeler; Jean Claude D'Halluin; Joe S Mymryk
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

3.  pRB-E2F1 complexes are resistant to adenovirus E1A-mediated disruption.

Authors:  L A Seifried; S Talluri; M Cecchini; L M Julian; J S Mymryk; F A Dick
Journal:  J Virol       Date:  2008-02-27       Impact factor: 5.103

4.  Phosphorylation within the transactivation domain of adenovirus E1A protein by mitogen-activated protein kinase regulates expression of early region 4.

Authors:  S G Whalen; R C Marcellus; A Whalen; N G Ahn; R P Ricciardi; P E Branton
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

5.  The cyclin-dependent kinase inhibitor roscovitine inhibits the transactivating activity and alters the posttranslational modification of herpes simplex virus type 1 ICP0.

Authors:  David J Davido; David A Leib; Priscilla A Schaffer
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

6.  Phosphorylation events during viral infections provide potential therapeutic targets.

Authors:  Julie A Keating; Rob Striker
Journal:  Rev Med Virol       Date:  2011-11-24       Impact factor: 6.989

Review 7.  Cancer Treatment Goes Viral: Using Viral Proteins to Induce Tumour-Specific Cell Death.

Authors:  Jasmine Wyatt; Manuel M Müller; Mahvash Tavassoli
Journal:  Cancers (Basel)       Date:  2019-12-07       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.